Loading viewer...
investor_presentation
Format: PDF investor_presentation
H. C. Wainwright & Co. Global Life Science Conference Recorded March 4, 2021
H. C. Wainwright & Co.
Global Life Science Conference
Recorded March 4, 2021The Private Securities Litigation Reform Act of 1995 provides a safe harbor from civil litigation for forward -looking statements accompanied by meaningful cautionary statements. Except
for historical information, this presentation contains forward -looking statements within the meaning of Section 27A of the Secur ities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, which may be identified by words such as “continues”, “estimates”, “anticipates”, “projects” , “plans”, “seeks”, “may”, “will”, “expects”, “intends”,
“believes”, “signals”, “should”, “can”, “guidance” and similar expressions or the negative versions thereof and which also ma y be identified by their context. All statements that address
operating performance or events or developments that Meridian expects or anticipates will occur in the future, including, but not limited to, statements relating to per share diluted net
earnings, sales, product demand, revenue, operating margin, other guidance and the impact of COVID -19 on its business and prospe cts, are forward -looking statements. Such
statements, whether expressed or implied, are based upon current expectations of the Company and speak only as of the date ma de.Specifically, Meridian’s forward -looking statements
are, and will be, based on management’s then -current views and assumptions regarding future events and operating performance. Me ridian assumes no obligation to publicly update or
revise any forward -looking statements even if experience or future changes make it clear that any projected results expressed or implied therein will not be realized. These statements
are subject to various risks, uncertainties and other factors that could cause actual results to differ materially, including , without limitation, the following:
Meridian’s operating results, financial condition and continued growth depends, in part, on its ability to introduce into the marketplace enhancements of existing products or new products
that incorporate technological advances, meet customer requirements and respond to products developed by Meridian’s competiti on,its ability to effectively sell such products and its
ability to successfully expand and effectively manage increased sales and marketing operations. While Meridian has introduced a number of internally developed products and acquired
products, there can be no assurance that it will be successful in the future in introducing such products on a timely basis o r in protecting its intellectual property, and unexpected or costly
manufacturing costs associated with its introduction of new products or acquired products could cause actual results to diffe r from expectations. Meridian relies on proprietary, patented
and licensed technologies. As such, the Company’s ability to protect its intellectual property rights, as well as the potenti al for intellectual property litigation, would impact its results.
Preview truncated — download the full document for the complete content.
investor_presentation
18 Pages
investor_presentation
44 Pages
Select Comfort Corporation
Varian Medical Systems Investor Presentation — July 2018
investor_presentationinvestor_presentation
36 Pages
Varian Medical Systems, Inc.
investor_presentation
BC Iron
investor_presentation
Steadfast Group
ICL Investor Presentation 2024
investor_presentationinvestor_presentation
80 Pages
ICL (Israel Chemicals Ltd)